Sharma et al., "Antibody Directed Enzyme Prodrug Therapy (ADEPT): A Three Phase System," Disease Markers, vol. 9, pp. 225-231, 1991. |
Bosslet et al., "A novel one-step tumor-selective prodrug activation system," Tumor Targeting, vol. 1, pp. 45-50, 1995. |
Blakey et al., "Anti-tumour effects of an antibody--carboxypeptidase G2 conjugate in combination with phenol mustard prodrugs," British Journal of Cancer, vol. 72, pp. 1083-1088, 1995. |
Bosslet et al., "Tumor-selective Prodrug Activation by Fusion Protein-mediated Catalysis," Cancer Research, vol. 54, No. 8, pp. 2151-2159, 1994. |
Trinh et al., "Enzyme/Prodrug Gene Therapy: Comparison of Cytosine Deaminase/5-Fluorocytosine Versus Thymidine Kinase/Ganciclovir Enzyme/Prodrug Systems in a Human Colorectal Carcinoma Cell Line," Cancer Research, vol. 55. pp. 4408-4812, 1995. |
Bagshawe, "Antibody directed anzymes revive anti-cancer prodrugs concept," Br. J. Cancer, vol. 56, pp. 531-532, 1987. |
Wang et al., "Activation of Glucuronide Prodrugs by Ligand-.beta.-glucuronidase Conjugates for Chemotherapy," Chem. Abst. No. 117782q, vol. 121, p. 625, (1994). |